Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Teruhisa, Kato"'
Autor:
Keita Fukao, Haruaki Nobori, Takayuki Kuroda, Kaoru Baba, Kazumi Matsumoto, Yukari Tanaka, Yuki Tachibana, Teruhisa Kato, Takao Shishido
Publikováno v:
Viruses, Vol 15, Iss 10, p 2052 (2023)
The small-molecule antiviral drug ensitrelvir targets the 3C-like protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study evaluated its inhibitory effect on viral replication in a delayed-treatment mouse model and investi
Externí odkaz:
https://doaj.org/article/d5518e9b9d154508a307272554b1b36c
Autor:
Takayuki Kuroda, Haruaki Nobori, Keita Fukao, Kaoru Baba, Kazumi Matsumoto, Shinpei Yoshida, Yukari Tanaka, Ryosuke Watari, Ryoko Oka, Yasuyuki Kasai, Kae Inoue, Sho Kawashima, Alice Shimba, Yoko Hayasaki-Kajiwara, Miki Tanimura, Qianhui Zhang, Yuki Tachibana, Teruhisa Kato, Takao Shishido
Publikováno v:
Journal of Antimicrobial Chemotherapy. 78:946-952
Objectives Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become established in the human population, making the need to develop safe and effective treatments critical. We have developed the small-molecule antiviral ensitrelvir, whi
Autor:
Sho Kawashima, Yuki Matsui, Takumi Adachi, Yuji Morikawa, Kae Inoue, Shiori Takebayashi, Haruaki Nobori, Masatomo Rokushima, Yuki Tachibana, Teruhisa Kato
Publikováno v:
Biochemical and Biophysical Research Communications. 645:132-136
Publikováno v:
YAKUGAKU ZASSHI. 142:691-696
Overcoming serious infectious diseases such as malaria, tuberculosis, and other neglected tropical diseases (NTDs) that threaten human life around the world is an important issue in global health. Most of these diseases are concentrated in developing
Autor:
Yuto Unoh, Shota Uehara, Kenji Nakahara, Haruaki Nobori, Yukiko Yamatsu, Shiho Yamamoto, Yuki Maruyama, Yoshiyuki Taoda, Koji Kasamatsu, Takahiro Suto, Kensuke Kouki, Atsufumi Nakahashi, Sho Kawashima, Takao Sanaki, Shinsuke Toba, Kentaro Uemura, Tohru Mizutare, Shigeru Ando, Michihito Sasaki, Yasuko Orba, Hirofumi Sawa, Akihiko Sato, Takafumi Sato, Teruhisa Kato, Yuki Tachibana
Publikováno v:
Journal of Medicinal Chemistry. 65:6499-6512
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in millions of deaths and threatens public health and safety. Despite the rapid global spread of COVID-19 vaccines,
Autor:
Michihito Sasaki, Koshiro Tabata, Mai Kishimoto, Yukari Itakura, Hiroko Kobayashi, Takuma Ariizumi, Kentaro Uemura, Shinsuke Toba, Shinji Kusakabe, Yuki Maruyama, Shun Iida, Noriko Nakajima, Tadaki Suzuki, Shinpei Yoshida, Haruaki Nobori, Takao Sanaki, Teruhisa Kato, Takao Shishido, William W. Hall, Yasuko Orba, Akihiko Sato, Hirofumi Sawa
Publikováno v:
Science Translational Medicine. 15
In parallel with vaccination, oral antiviral agents are highly anticipated to act as countermeasures for the treatment of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Oral an
Autor:
Haruaki Nobori, Keita Fukao, Takayuki Kuroda, Naomi Anan, Ryoichi Tashima, Masaaki Nakashima, Sayuri Noda, Minako Tajiri, Mikinori Torii, Shinsuke Toba, Kentaro Uemura, Takao Sanaki, Takao Shishido, Yuki Tachibana, Teruhisa Kato
Publikováno v:
The Journal of antimicrobial chemotherapy. 77(11)
Objectives Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of coronavirus disease 2019 (COVID-19) and a devastating worldwide health concern. Development of safe and effective treatments is not only important fo
Autor:
Michihito Sasaki, Koshiro Tabata, Mai Kishimoto, Yukari Itakura, Hiroko Kobayashi, Takuma Ariizumi, Kentaro Uemura, Shinsuke Toba, Shinji Kusakabe, Yuki Maruyama, Shun Iida, Noriko Nakajima, Tadaki Suzuki, Shinpei Yoshida, Haruaki Nobori, Takao Sanaki, Teruhisa Kato, Takao Shishido, William W. Hall, Yasuko Orba, Akihiko Sato, Hirofumi Sawa
In parallel with vaccination, oral antiviral agents are highly anticipated to act as countermeasures for the treatment of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Oral an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0cd5d8e6182084f0d894f08b1ffa234
https://doi.org/10.1101/2022.02.14.480338
https://doi.org/10.1101/2022.02.14.480338
Autor:
Yasuhito Taniguchi, Takeshi Aihara, Teruhisa Kato, Akiko Hirao, Minoru Sakakibara, Hiroki Mori, Nobuyuki Takahashi, Hiroyuki Ohshiro, Yasuo Ochi, Hiroko Tonai-Kachi, Yoichi Kurebayashi
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 328:671-679
Inhibition of H(+),K(+)-ATPase is accepted as the most effective way of controlling gastric acid secretion. However, current acid suppressant therapy for gastroesophageal reflux disease, using histamine H(2) receptor antagonists and proton pump inhib
Autor:
Saburo Matsui, Hiroshi Handa, Tomonari Matsuda, Teruhisa Kato, Mitsuru Iida, Kentaro Misaki, Masato Suzuki, Masafumi Nakamura
Publikováno v:
Archives of Environmental Contamination and Toxicology. 55:199-209
A wide variety of contaminants derived from diesel and gasoline engines, tire, asphalt, and natural organic compounds is found in road dust. Polycyclic aromatic compounds (PACs) are the important toxic targets among various contents in road dust and